A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions

NCT05729386 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: GC2129A(Period 1)
DRUG: Linaglptin 5mg and Metformin Hydrocholoride 1000mg(Period 1)
DRUG: GC2129A(Period 2)
DRUG: Linaglptin 5mg and Metformin Hydrochloride 1000mg(Period 2)

Sponsor

GC Biopharma Corp